| Financial Year |
March 31 2023 |
| Monetary Funds |
93,908,551.32 |
| Held-for-trading Financial Assets |
242,196.62 |
| Notes Receivable |
1,198,000.78 |
| Accounts Receivable |
385,357,475.28 |
| Advances to Suppliers |
25,140,177.74 |
| Other Receivables |
7,530,802.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
476,675,216.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,234,667.52 |
| Total Current Assets |
1,088,906,400.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
49,754,587.48 |
| Investment Properties |
15,024,539.67 |
| Fixed Assetes |
783,877,603.42 |
| Under-construction Projects |
16,762,342.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
111,731,634.89 |
| R&D expenses |
-- |
| Goodwill |
34,203,385.98 |
| Long-Term Deferred and Prepaid Expenses |
17,935,739.52 |
| Deferred Income Tax Assets |
18,054,100.14 |
| Other Non-Current Assets |
110,110,113.21 |
| Sub-Total of Non-Current Assets |
1,182,182,701.54 |
| Total Assets |
2,271,089,101.99 |
| Short-Term Loans |
302,977,754.14 |
| Trading Financial liabilities |
-- |
| Notes Payable |
35,000,000.00 |
| Accounts Payable |
392,693,828.63 |
| Accounts Received In Advance |
12,028,968.44 |
| Employee Compensation Payable |
26,690,662.65 |
| Taxes Payable |
22,426,198.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
63,892,922.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,148,853.52 |
| Other Current Liabilities |
15,744,422.66 |
| Sub-Total of Current Liabilities |
938,545,727.39 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,001,147.83 |
| Deferred Income Tax Liabilities |
1,159,550.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
33,396,981.38 |
| Total Liabilities |
971,942,708.77 |
| Paid-In Capital(Or Share Stock) |
532,173,689.00 |
| Capital Surplus |
1,081,722,927.14 |
| Surplus Reserve |
44,506,065.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-361,909,036.05 |
| Minority Stockholder's Interest |
2,652,747.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,296,493,645.24 |
| Owner's Equity（Stockholder's Equity） |
1,299,146,393.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,271,089,101.99 |
